X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-25 | AKBA | Hadas Nicole R. | SVP, GC | S - Sale+OE | $1.22 | -63,186 | 524,344 | -11% | -$77,270 | |||||
| D | 2023-05-25 | AKBA | Dahan Michel | SVP, COO | S - Sale+OE | $1.22 | -95,478 | 574,037 | -14% | -$116,760 | |||||
2023-05-16 | AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S - Sale | $1.07 | -63,567 | 530,487 | -11% | -$67,890 | ||||||
2023-05-16 | AKBA | Spellman David A | SVP, CFO, Treasurer | S - Sale | $1.07 | -63,567 | 446,483 | -12% | -$67,890 | ||||||
2023-03-01 | AKBA | Butler John P. | CEO, Pres | S - Sale | $0.88 | -91,868 | 1,888,728 | -5% | -$80,614 | ||||||
2023-03-01 | AKBA | Hadas Nicole R. | SVP, GC | S - Sale | $0.88 | -13,034 | 287,530 | -4% | -$11,437 | ||||||
2023-03-01 | AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S - Sale | $0.88 | -14,123 | 594,054 | -2% | -$12,393 | ||||||
2023-03-01 | AKBA | Dahan Michel | SVP, COO | S - Sale | $0.88 | -20,412 | 269,515 | -7% | -$17,912 | ||||||
2023-03-01 | AKBA | Spellman David A | SVP, CFO, Treasurer | S - Sale | $0.88 | -7,210 | 510,050 | -1% | -$6,327 | ||||||
2023-02-27 | AKBA | Butler John P. | CEO, Pres | S - Sale | $0.81 | -38,632 | 1,980,596 | -2% | -$31,416 | ||||||
2023-02-27 | AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S - Sale | $0.81 | -7,539 | 608,177 | -1% | -$6,131 | ||||||
2023-02-27 | AKBA | Dahan Michel | SVP, COO | S - Sale | $0.81 | -10,090 | 289,927 | -3% | -$8,205 | ||||||
2023-02-27 | AKBA | Spellman David A | SVP, CFO, Treasurer | S - Sale | $0.81 | -7,539 | 517,260 | -1% | -$6,131 | ||||||
2023-02-27 | AKBA | Hadas Nicole R. | SVP, GC | S - Sale | $0.81 | -6,677 | 300,564 | -2% | -$5,430 | ||||||
2022-08-31 | AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S - Sale | $0.36 | -1,147 | 418,016 | 0% | -$416 | ||||||
2022-06-03 | AKBA | Gilman Steven C | Dir | S - Sale | $0.36 | -4,567 | 43,430 | -10% | -$1,653 | ||||||
| DM | 2022-02-28 | AKBA | Butler John P. | CEO, Pres | S - Sale+OE | $2.17 | -79,026 | 1,723,103 | -4% | -$171,143 | |||||
| DM | 2022-02-28 | AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S - Sale+OE | $2.16 | -15,056 | 217,663 | -6% | -$32,564 | |||||
| D | 2022-02-28 | AKBA | Cotreau Violetta | SVP, Chief Accounting Officer | S - Sale+OE | $2.15 | -3,946 | 69,954 | -5% | -$8,503 | |||||
| DM | 2022-02-28 | AKBA | Dahan Michel | SVP, COO | S - Sale+OE | $2.17 | -21,533 | 297,017 | -7% | -$46,637 | |||||
| DM | 2022-02-28 | AKBA | Faulkingham Dell | SVP, CCO | S - Sale+OE | $2.16 | -13,184 | 173,841 | -7% | -$28,515 | |||||
| DM | 2022-02-28 | AKBA | Hadas Nicole R. | SVP, GC | S - Sale+OE | $2.17 | -21,062 | 304,241 | -6% | -$45,615 | |||||
| DM | 2022-02-28 | AKBA | Spellman David A | SVP, CFO, Treasurer | S - Sale+OE | $2.16 | -8,203 | 128,599 | -6% | -$17,689 | |||||
2022-01-03 | AKBA | Cotreau Violetta | SVP, Chief Accounting Officer | S - Sale | $2.29 | -5,833 | 33,067 | -15% | -$13,335 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |